右半结肠二次前视检查与单次前视检查对腺瘤检出率的国际多中心随机试验
这项国际多中心随机试验将1011例接受筛查或监测结肠镜的无症状个体随机分为右半结肠二次前视检查组(502例)和标准单次前视检查组(509例),比较右半结肠腺瘤检出率。结果显示二次前视检查组右半结肠腺瘤检出率显著高于标准组(27.1% vs 21.6%,P=.042),全结肠腺瘤检出率两组无显著差异(49.0% vs 45.0%,P=.201),二次前视检查组中位总体退镜时间延长1.5分钟(12.0 vs 10.5分钟,P<.001)。作者认为常规右半结肠二次前视检查应考虑采用。
要点
- 二次前视检查组右半结肠腺瘤检出率27.1%,显著高于标准组的21.6%(P=.042)。
- 全结肠腺瘤检出率两组无显著差异:二次前视检查组49.0% vs 标准组45.0%(P=.201)。
- 二次前视检查导致15例(3.0%)监测建议改变,中位总体退镜时间延长1.5分钟。
核心结论
- 在这项多中心试验中,右半结肠二次前视检查显著提高了筛查和监测结肠镜的右半结肠腺瘤检出率。
- 作者认为常规右半结肠二次前视检查应考虑采用。
研究设计与样本
- 国际多中心随机试验,纳入来自6个亚太地区接受筛查或监测结肠镜的无症状个体。
- 所有患者先完成右半结肠前视检查,随后在肝曲随机分为右半结肠二次前视检查加标准退镜组(502例)或标准退镜组(509例)。
- 共1011例患者随机,45名内镜医师完成结肠镜检查,研究时间为2016年至2019年。
- 主要结局为右半结肠腺瘤检出率。
主要发现
- 右半结肠腺瘤检出率二次前视检查组为27.1%,标准退镜组为21.6%,二次前视检查组显著更高(P=.042)。
- 全结肠腺瘤检出率二次前视检查组为49.0%,标准退镜组为45.0%,两组无显著差异(P=.201)。
- 二次前视检查在49例患者(9.8%)中额外检出58个腺瘤,并使15例患者(3.0%)的监测建议发生改变。
- 中位总体退镜时间二次前视检查组为12.0分钟,标准退镜组为10.5分钟,二次前视检查组延长1.5分钟(P<.001)。
- 年龄较大、男性、曾吸烟和右半结肠退镜时间较长是右侧腺瘤检出的独立预测因素。
临床怎么用
- 作者认为常规右半结肠二次前视检查应考虑采用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Second forward view (SFV) examination of the right colon (RC) in colonoscopy was suggested to improve the adenoma detection rate (ADR), but multicenter data to inform its routine use remain limited. We performed an international multicenter randomized trial comparing SFV vs a standard single forward view examination of the RC on adenoma detection. METHODS: Asymptomatic individuals undergoing screening or surveillance colonoscopies from 6 Asia Pacific regions were invited for study. A forward view examination of the RC was first performed in all patients, followed by randomization at the hepatic flexure to either SFV examination of the RC and standard withdrawal examination from the hepatic flexure to rectum, or a standard withdrawal colonoscopy (SWC) examination from the hepatic flexure to rectum. The primary outcome was RC ADR. RESULTS: Between 2016 and 2019, there were 1011 patients randomized (SFV group, 502 patients; SWC group, 509 patients). Forty-five endoscopists performed the colonoscopies. The RC ADR was significantly higher in the SFV group than in the SWC group (27.1% vs 21.6%; P = .042). The whole-colon ADR was high in both groups (49.0% vs 45.0%; P =.201). The SFV examination identified 58 additional adenomas in 49 patients (9.8%), leading to a change in surveillance recommendations in 15 patients (3.0%). The median overall withdrawal time was 1.5 minutes longer in the SFV group (12.0 vs 10.5 min; P < .001). Older age, male sex, ever smoking, and longer RC withdrawal time were independent predictors of right-sided adenoma detection. CONCLUSIONS: In this multicenter trial, SFV examination significantly increased the RC ADR in screening and surveillance colonoscopies. Routine RC SFV examination should be considered. ClinicalTrials.gov ID: NCT03121495.
引用
- Tang RSY, Lee JWJ, Chang LC, et al. Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial. Clin Gastroenterol Hepatol. 2020. PMID: 33065307. doi:10.1016/j.cgh.2020.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。